Propanc Biopharma Reports Net Loss of $2.7 Million for the Year
Annual revenue of $0 million
By USInMinutes
Published - Oct 07, 2023, 01:08 PM ET
Last Updated - Oct 07, 2023, 01:09 PM EDT
Propanc Biopharma, Inc. [PPCB] has reported a net loss of $2.7 million for the fiscal year ended June 30, 2023. The company's annual revenue remained at $0 million for the same period.
Financial Performance
Despite the net loss, Propanc Biopharma managed to improve its financial performance compared to the previous year. The company's operating expenses decreased from $1.99 million to $1.77 million, indicating a more efficient use of resources. However, these improvements were not enough to generate positive earnings.
